Schroder Adveq

Summary

Schroder Adveq appeared to be the VC, which was created in 1997. The company was established in Europe in Switzerland. The leading representative office of defined VC is situated in the Zu00fcrich.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Health Diagnostics. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - Switzerland. Among the various public portfolio startups of the fund, we may underline Decibel Therapeutics, Nohla Therapeutics, Memo Therapeutics

Besides them, we counted 13 critical employees of this fund in our database.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Schroder Adveq, startups are often financed by Third Rock Ventures, Venture Kick, Lightspeed China Partners. The meaningful sponsors for the fund in investment in the same round are VI Partners AG, Third Rock Ventures, Redalpine Venture Partners. In the next rounds fund is usually obtained by Vivo Capital, VI Partners AG, Third Rock Ventures.

The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2018. The increased amount of exits for fund were in 2019. Opposing the other organizations, this Schroder Adveq works on 18 percentage points less the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars.